Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07740603

Study of CD38 and CD56 in Chronic Myeloid Leukemia

Conditions: Chronic Myeloid Leukemia (CML)

Sex: All

Healthy volunteers: Yes

Enrollment: 200

Sponsor: Sohag University

Summary

Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow. The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.

Eligibility Criteria

Inclusion Criteria: * patients with chronic myeloid leukemia Exclusion Criteria: * other hematological diseases

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07740603). StuddyBuddy aggregates publicly available trial information.